Several elegant previous in vivo studies utilizing either CRISPR-based or gene knockout approaches demonstrated that loss of SETD2 promotes lung adenocarcinoma (LUAD) tumorigenesis in the canonical KRASG12D-driven LUAD mouse tumor model (22, 30–33). This evidence concerns the gene SETD2 and lung adenocarcinoma.